KOPRANPharmaceuticals

Kopran LtdCash Flow Statement

108.04
-6.75%

Kopran Ltd Cash Flow Statement (Annual)

Metric20252024202320222021
Issuance Of Capital Stock1.34 Cr0.000.00126.48 Cr
Capital Expenditure-58.92 Cr-56.61 Cr-61.05 Cr-42.27 Cr
End Cash Position19.47 Cr8.09 Cr7.40 Cr5.87 Cr
Beginning Cash Position8.09 Cr7.40 Cr5.87 Cr0.94 Cr
Effect Of Exchange Rate Changes0.000.000.000.00
Changes In Cash11.38 Cr0.69 Cr1.53 Cr4.93 Cr
Financing Cash Flow25.87 Cr0.99 Cr-19.84 Cr122.82 Cr
Net Other Financing Charges-0.07 Cr0.05 Cr0.02 Cr-0.30 Cr
Interest Paid Cff-9.34 Cr-8.59 Cr-6.08 Cr-5.19 Cr
Cash Dividends Paid-14.46 Cr-14.46 Cr-14.46 Cr-6.49 Cr
Net Common Stock Issuance1.34 Cr0.000.00126.48 Cr
Common Stock Issuance1.34 Cr0.000.00126.48 Cr
Net Issuance Payments Of Debt48.40 Cr23.99 Cr0.68 Cr8.33 Cr
Net Short Term Debt Issuance48.08 Cr25.27 Cr1.57 Cr10.47 Cr
Short Term Debt Issuance48.08 Cr25.27 Cr1.57 Cr10.48 Cr
Net Long Term Debt Issuance0.32 Cr-1.28 Cr-0.89 Cr-2.14 Cr
Long Term Debt Payments-0.02 Cr-1.29 Cr-0.89 Cr-2.14 Cr
Long Term Debt Issuance0.35 Cr62000.000.18 Cr
Investing Cash Flow-56.43 Cr-43.55 Cr-12.65 Cr-84.42 Cr
Net Other Investing Changes2.76 Cr13.41 Cr-0.08 Cr-0.30 Cr
Interest Received Cfi0.32 Cr0.30 Cr1.70 Cr1.32 Cr
Dividends Received Cfi9000.005000.007000.007000.00
Net Investment Purchase And Sale-0.12 Cr-0.35 Cr46.51 Cr-43.02 Cr
Purchase Of Investment-0.12 Cr-0.35 Cr-45.30 Cr-5.32 Cr
Net Intangibles Purchase And Sale-4.02 Cr-6.47 Cr-6.15 Cr-2.68 Cr
Purchase Of Intangibles-4.02 Cr-6.47 Cr-6.15 Cr-2.68 Cr
Net PPE Purchase And Sale-54.88 Cr-50.15 Cr-54.90 Cr-39.58 Cr
Sale Of PPE0.02 Cr0.000.000.01 Cr
Purchase Of PPE-54.90 Cr-50.15 Cr-54.90 Cr-39.59 Cr
Operating Cash Flow41.94 Cr43.26 Cr34.02 Cr-33.48 Cr
Taxes Refund Paid-13.25 Cr-14.33 Cr-12.79 Cr-18.27 Cr
Change In Working Capital-21.56 Cr-30.91 Cr-5.55 Cr-110.81 Cr
Change In Other Current Liabilities14.56 Cr-9.70 Cr1.66 Cr3.25 Cr
Change In Other Current Assets-4.51 Cr9.80 Cr-17.83 Cr-34.96 Cr
Change In Payable2.08 Cr15.29 Cr64.90 Cr-25.58 Cr
Change In Inventory-30.23 Cr-7.87 Cr19.33 Cr-49.94 Cr
Change In Receivables-4.32 Cr-39.35 Cr-74.46 Cr-4.52 Cr
Other Non Cash Items8.94 Cr8.07 Cr4.36 Cr3.12 Cr
Stock Based Compensation1.30 Cr1.03 Cr0.00
Provisionand Write Offof Assets-46000.00-0.06 Cr0.21 Cr0.31 Cr
Depreciation And Amortization15.59 Cr12.89 Cr12.71 Cr11.10 Cr
Depreciation15.59 Cr12.89 Cr11.96 Cr10.38 Cr
Gain Loss On Investment Securities-9000.00-5000.00-7000.0015000.00
Net Foreign Currency Exchange Gain Loss-1.03 Cr-0.98 Cr-0.99 Cr-0.73 Cr
Gain Loss On Sale Of PPE13000.000.000.000.01 Cr
Net Income From Continuing Operations51.95 Cr67.54 Cr36.07 Cr81.78 Cr
Free Cash Flow-16.98 Cr-13.36 Cr-27.02 Cr-75.75 Cr
Repayment Of Debt-0.02 Cr-1.29 Cr-0.89 Cr-2.15 Cr
Issuance Of Debt48.43 Cr25.28 Cr1.57 Cr10.48 Cr
Sale Of Investment0.0046.51 Cr2.28 Cr0.00
Short Term Debt Payments-0.02 Cr-0.01 Cr-8.66 Cr
Net Business Purchase And Sale0.000.00
Purchase Of Business0.000.00
Amortization Cash Flow0.75 Cr0.72 Cr0.62 Cr
Net Preferred Stock Issuance0.00
Preferred Stock Payments0.00
Capital Expenditure Reported-23.62 Cr
Repurchase Of Capital Stock0.00

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.